Amy Li
Impact in
-
- Diphtheria, Corynebacterium, and Tetanus
Papers in
-
- Hedgehog Signaling Pathway Studies 3
- Metabolomics and Mass Spectrometry Studies 2
- Surgery 3
- Cholesterol and Lipid Metabolism 3
- Co-authors
- Libin Xu (13 shared papers)Kelly M. Hines (3 shared papers)Ilya Alexandrov (1 shared paper)Yongmei Wang (1 shared paper)Stefano Monti (1 shared paper)Xiongbin Lu (1 shared paper)Michael Y. Sherman (1 shared paper)Julia A. Yaglom (1 shared paper)
- Journals
- Nature Communications (1 paper)Neuro-Oncology (1 paper)Clinical and Experimental Ophthalmology (1 paper)ACS Infectious Diseases (1 paper)Biophysical Journal (1 paper)
- Partner nations
- United StatesIsraelChina
In The Last Decade
Amy Li
16 papers receiving 202 citations
Peers
Comparison fields: 5 of 58
- Endocrinology 15
- Aging 5
- Microbiology 13
- Molecular Biology 139
- Cell Biology 24
Countries citing papers authored by Amy Li
This map shows the geographic impact of Amy Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Li more than expected).
Fields of papers citing papers by Amy Li
This network shows the impact of papers produced by Amy Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Li. The network helps show where Amy Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 50 | |
| 2 | 2019 | 30 | |
| 3 | 2020 | 24 | |
| 4 | 2022 | 20 | |
| 5 | 2020 | 18 | |
| 6 | 2021 | 17 | |
| 7 | 2000 | 16 | |
| 8 | 2022 | 6 | |
| 9 | 2024 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2025 | 4 | |
| 12 | 2022 | 3 | |
| 13 | 2024 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2020 | 1 |
About Amy Li
Amy Li is a scholar working on Molecular Biology, Surgery, Genetics, Pulmonary and Respiratory Medicine and Clinical Biochemistry, having authored 16 papers that have together received 204 indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (3 papers), Cholesterol and Lipid Metabolism (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer, Lipids, and Metabolism (2 papers), Lipid metabolism and biosynthesis (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Genetic and Kidney Cyst Diseases (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Endocrinology (15 citations), Aging (5 citations), Microbiology (13 citations), Molecular Biology (139 citations) and Cell Biology (24 citations). Amy Li has collaborated with scholars based in United States, Israel and China. Frequent co-authors include Libin Xu, Kelly M. Hines, Ilya Alexandrov, Yongmei Wang, Stefano Monti, Xiongbin Lu, Michael Y. Sherman, Julia A. Yaglom, David R. Raleigh and Biswajit Mishra. Their work appears in journals such as Nature Communications, Neuro-Oncology, Clinical and Experimental Ophthalmology, ACS Infectious Diseases and Biophysical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.